CVS Health Corporation

Equities

CVS

US1266501006

Healthcare Facilities & Services

Market Closed - Nyse 01:30:02 09/05/2024 am IST 5-day change 1st Jan Change
54.91 USD -1.49% Intraday chart for CVS Health Corporation -18.90% -30.46%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Argus Research Adjusts Price Target on CVS Health to $80 From $100 MT
Mickey Mouse on Wall Street Our Logo
ANALYST RECOMMENDATIONS : Walt Disney, Tractor Supply Company, KKR, Occidental Petroleum... Our Logo
CVS Health Files Prospectus Supplement for Notes Sale MT
FOMO is Back Our Logo
ANALYST RECOMMENDATIONS : Nvidia, The Home Depot, Lowe's, Rollins... Our Logo
Wells Fargo Adjusts CVS Health's Price Target to $60 From $76 MT
TD Cowen Downgrades CVS Health to Hold From Buy, Adjusts Price Target to $59 From $99 MT
Ameriprise Downgrades CVS Health to Hold From Buy MT
Aetna will cover fertility treatments for LGBTQ people under court settlement RE
ARC Independent Research Adjusts Price Target on CVS Health to $65 From $80 MT
Wall Street rises thanks to good and bad economic news Our Logo
North American Morning Briefing : Apple, Amgen -2- DJ
ANALYST RECOMMENDATIONS : Alphabet, Amgen, Starbucks, PayPal, Moderna... Our Logo
HSBC Downgrades CVS Health to Hold From Buy, Adjusts Price Target to $62 From $91 MT
Cvs Health Insider Bought Shares Worth $500,294, According to a Recent SEC Filing MT
Deutsche Bank Adjusts Price Target on CVS Health to $64 From $77 MT
Raymond James Adjusts Price Target on CVS Health to $65 From $85 MT
Wolfe Adjusts Price Target on CVS Health to $70 From $88 MT
Morgan Stanley Adjusts Price Target on CVS Health to $65 From $85 MT
Jefferies Adjusts Price Target on CVS Health to $72 From $95 MT
Barclays Adjusts Price Target on CVS Health to $63 From $78 MT
Bernstein Adjusts Price Target on CVS Health to $62 From $93 MT
Mizuho Adjusts Price Target on CVS Health to $72 From $86 MT
Truist Lowers CVS Health's PT to $66 From $90 After Below-Consensus Q1 Results, Reduced Guidance; Keeps Buy Rating MT
Chart CVS Health Corporation
More charts
CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
54.91 USD
Average target price
71.37 USD
Spread / Average Target
+29.98%
Consensus
  1. Stock Market
  2. Equities
  3. CVS Stock
  4. News CVS Health Corporation
  5. CVS Health : Deutsche Bank Adjusts Price Target for CVS Health to $99 From $102, Maintains Buy Rating
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW